Annual CFI
-$486.60 M
+$29.43 M+5.70%
31 March 2024
Summary:
Dr Reddys Laboratories Limited annual cash flow from investing activities is currently -$486.60 million, with the most recent change of +$29.43 million (+5.70%) on 31 March 2024. During the last 3 years, it has fallen by -$181.92 million (-59.71%). RDY annual CFI is now -3542.66% below its all-time high of $14.13 million, reached on 31 March 2005.RDY Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$226.63 M
+$16.07 M+6.62%
01 September 2024
Summary:
Dr Reddys Laboratories Limited quarterly cash flow from investing activities is currently -$226.63 million, with the most recent change of +$16.07 million (+6.62%) on 01 September 2024. Over the past year, it has dropped by -$172.65 million (-319.80%). RDY quarterly CFI is now -273.40% below its all-time high of $130.70 million, reached on 30 June 2016.RDY Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$801.71 M
-$172.65 M-27.45%
01 September 2024
Summary:
Dr Reddys Laboratories Limited TTM cash flow from investing activities is currently -$801.71 million, with the most recent change of -$172.65 million (-27.45%) on 01 September 2024. Over the past year, it has dropped by -$121.29 million (-17.83%). RDY TTM CFI is now -1418.60% below its all-time high of $60.80 million, reached on 30 June 2005.RDY TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RDY Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.7% | -319.8% | -17.8% |
| 3 y3 years | -59.7% | -520.3% | -708.8% |
| 5 y5 years | -340.5% | -1282.8% | -327.6% |
RDY Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -59.7% | +5.7% | -406.4% | +29.6% | -708.8% | at low |
| 5 y | 5 years | -601.9% | +5.7% | -297.2% | +29.6% | -2440.7% | at low |
| alltime | all time | -3542.7% | +38.0% | -273.4% | +68.3% | -1418.6% | at low |
Dr Reddys Laboratories Limited Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$226.63 M(-6.6%) | -$801.71 M(+27.4%) |
| June 2024 | - | -$242.71 M(+74.5%) | -$629.06 M(+29.3%) |
| Mar 2024 | -$486.60 M(-5.7%) | -$139.12 M(-28.0%) | -$486.60 M(-11.8%) |
| Dec 2023 | - | -$193.25 M(+258.0%) | -$551.76 M(-18.9%) |
| Sept 2023 | - | -$53.99 M(-46.1%) | -$680.42 M(+23.2%) |
| June 2023 | - | -$100.25 M(-50.9%) | -$552.47 M(+7.1%) |
| Mar 2023 | -$516.03 M(+45.7%) | -$204.28 M(-36.5%) | -$516.03 M(-15.0%) |
| Dec 2022 | - | -$321.90 M(-535.2%) | -$607.29 M(+88.6%) |
| Sept 2022 | - | $73.96 M(-215.9%) | -$321.96 M(-5.9%) |
| June 2022 | - | -$63.81 M(-78.4%) | -$342.00 M(-3.5%) |
| Mar 2022 | -$354.22 M(+16.3%) | -$295.54 M(+708.0%) | -$354.22 M(+91.7%) |
| Dec 2021 | - | -$36.58 M(-167.8%) | -$184.75 M(+86.4%) |
| Sept 2021 | - | $53.92 M(-170.9%) | -$99.12 M(-43.1%) |
| June 2021 | - | -$76.03 M(-39.7%) | -$174.32 M(-42.8%) |
| Mar 2021 | -$304.68 M(+339.5%) | -$126.07 M(-357.0%) | -$304.68 M(+3.8%) |
| Dec 2020 | - | $49.06 M(-330.6%) | -$293.47 M(+28.9%) |
| Sept 2020 | - | -$21.28 M(-89.7%) | -$227.63 M(+2.2%) |
| June 2020 | - | -$206.39 M(+79.7%) | -$222.74 M(+221.3%) |
| Mar 2020 | -$69.32 M(-37.2%) | -$114.86 M(-200.0%) | -$69.32 M(-302.4%) |
| Dec 2019 | - | $114.90 M(-801.1%) | $34.25 M(-118.3%) |
| Sept 2019 | - | -$16.39 M(-69.1%) | -$187.48 M(-12.8%) |
| June 2019 | - | -$52.97 M(+369.3%) | -$215.08 M(+94.7%) |
| Mar 2019 | -$110.46 M(-52.2%) | -$11.29 M(-89.4%) | -$110.46 M(+26.0%) |
| Dec 2018 | - | -$106.83 M(+142.8%) | -$87.66 M(-36.6%) |
| Sept 2018 | - | -$43.99 M(-185.2%) | -$138.33 M(-21.3%) |
| June 2018 | - | $51.64 M(+348.6%) | -$175.69 M(-23.9%) |
| Mar 2018 | -$230.85 M(-16.2%) | $11.51 M(-107.3%) | -$230.85 M(-20.9%) |
| Dec 2017 | - | -$157.49 M(+93.6%) | -$291.85 M(+186.1%) |
| Sept 2017 | - | -$81.35 M(+2211.4%) | -$101.99 M(-75.1%) |
| June 2017 | - | -$3.52 M(-92.9%) | -$409.67 M(+48.7%) |
| Mar 2017 | -$275.45 M(-11.8%) | -$49.48 M(-252.9%) | -$275.45 M(-10.2%) |
| Dec 2016 | - | $32.36 M(-108.3%) | -$306.59 M(-35.4%) |
| Sept 2016 | - | -$389.03 M(-397.6%) | -$474.25 M(+337.5%) |
| June 2016 | - | $130.70 M(-262.1%) | -$108.39 M(-65.3%) |
| Mar 2016 | -$312.20 M(-16.7%) | -$80.63 M(-40.4%) | -$312.20 M(-33.4%) |
| Dec 2015 | - | -$135.30 M(+484.2%) | -$468.43 M(-2.7%) |
| Sept 2015 | - | -$23.16 M(-68.3%) | -$481.33 M(+21.7%) |
| June 2015 | - | -$73.11 M(-69.1%) | -$395.38 M(+5.5%) |
| Mar 2015 | -$374.69 M(+35.8%) | -$236.85 M(+59.8%) | -$374.69 M(-9.6%) |
| Dec 2014 | - | -$148.20 M(-336.0%) | -$414.36 M(+92.7%) |
| Sept 2014 | - | $62.79 M(-219.8%) | -$215.08 M(-9.8%) |
| June 2014 | - | -$52.43 M(-81.0%) | -$238.55 M(-13.5%) |
| Mar 2014 | -$275.83 M(+7.5%) | -$276.52 M(-641.4%) | -$275.83 M(+199.4%) |
| Dec 2013 | - | $51.08 M(+29.9%) | -$92.13 M(-51.2%) |
| Sept 2013 | - | $39.32 M(-143.8%) | -$188.74 M(-30.1%) |
| June 2013 | - | -$89.70 M(-3.4%) | -$270.13 M(+5.3%) |
| Mar 2013 | -$256.56 M | -$92.82 M(+103.9%) | -$256.56 M(-34.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | - | -$45.53 M(+8.2%) | -$389.65 M(+9.4%) |
| Sept 2012 | - | -$42.07 M(-44.7%) | -$356.12 M(-8.7%) |
| June 2012 | - | -$76.13 M(-66.3%) | -$389.93 M(-0.3%) |
| Mar 2012 | -$391.16 M(+105.7%) | -$225.91 M(+1781.6%) | -$391.16 M(+72.4%) |
| Dec 2011 | - | -$12.01 M(-84.2%) | -$226.83 M(-33.2%) |
| Sept 2011 | - | -$75.88 M(-1.9%) | -$339.40 M(+33.0%) |
| June 2011 | - | -$77.36 M(+25.6%) | -$255.13 M(+34.2%) |
| Mar 2011 | -$190.18 M(+28.7%) | -$61.58 M(-50.6%) | -$190.18 M(-6.9%) |
| Dec 2010 | - | -$124.57 M(-1585.6%) | -$204.27 M(+61.7%) |
| Sept 2010 | - | $8.39 M(-167.6%) | -$126.35 M(-17.8%) |
| June 2010 | - | -$12.41 M(-83.6%) | -$153.77 M(+4.1%) |
| Mar 2010 | -$147.75 M(+95.3%) | -$75.67 M(+62.2%) | -$147.75 M(+54.0%) |
| Dec 2009 | - | -$46.66 M(+145.1%) | -$95.96 M(+117.9%) |
| Sept 2009 | - | -$19.03 M(+198.0%) | -$44.03 M(+244.9%) |
| June 2009 | - | -$6.39 M(-73.3%) | -$12.77 M(-83.1%) |
| Mar 2009 | -$75.65 M(-67.6%) | -$23.89 M(-552.9%) | -$75.65 M(-35.3%) |
| Dec 2008 | - | $5.27 M(-56.9%) | -$117.01 M(-46.6%) |
| Sept 2008 | - | $12.23 M(-117.7%) | -$219.06 M(-23.1%) |
| June 2008 | - | -$69.27 M(+6.2%) | -$284.84 M(+21.9%) |
| Mar 2008 | -$233.74 M(-1873.4%) | -$65.25 M(-32.6%) | -$233.74 M(+16.2%) |
| Dec 2007 | - | -$96.77 M(+80.7%) | -$201.19 M(+340.0%) |
| Sept 2007 | - | -$53.55 M(+194.8%) | -$45.73 M(+192.0%) |
| June 2007 | - | -$18.17 M(-44.4%) | -$15.66 M(-218.8%) |
| Mar 2007 | $13.18 M(-101.7%) | -$32.70 M(-155.7%) | $13.18 M(-102.0%) |
| Dec 2006 | - | $58.69 M(-349.9%) | -$669.63 M(-15.5%) |
| Sept 2006 | - | -$23.49 M(-320.0%) | -$792.65 M(+3.1%) |
| June 2006 | - | $10.68 M(-101.5%) | -$768.61 M(-2.0%) |
| Mar 2006 | -$784.43 M(-5649.8%) | -$715.51 M(+1012.3%) | -$784.43 M(+1452.7%) |
| Dec 2005 | - | -$64.33 M(<-9900.0%) | -$50.52 M(-841.2%) |
| Sept 2005 | - | $554.70 K(-110.8%) | $6.82 M(-88.8%) |
| June 2005 | - | -$5.15 M(-128.0%) | $60.80 M(+330.2%) |
| Mar 2005 | $14.13 M(-110.0%) | $18.41 M(-363.3%) | $14.13 M(-123.4%) |
| Dec 2004 | - | -$6.99 M(-112.8%) | -$60.35 M(-46.2%) |
| Sept 2004 | - | $54.54 M(-205.2%) | -$112.11 M(-38.9%) |
| June 2004 | - | -$51.82 M(-7.6%) | -$183.37 M(+29.2%) |
| Mar 2004 | -$141.97 M(+252.7%) | -$56.08 M(-4.6%) | -$141.97 M(+49.4%) |
| Dec 2003 | - | -$58.75 M(+251.5%) | -$95.06 M(+110.8%) |
| Sept 2003 | - | -$16.72 M(+60.3%) | -$45.08 M(+22.8%) |
| June 2003 | - | -$10.43 M(+13.8%) | -$36.72 M(-8.8%) |
| Mar 2003 | -$40.25 M(+25.5%) | -$9.16 M(+4.4%) | -$40.25 M(-12.0%) |
| Dec 2002 | - | -$8.78 M(+5.1%) | -$45.75 M(+5.1%) |
| Sept 2002 | - | -$8.35 M(-40.1%) | -$43.51 M(+3.1%) |
| June 2002 | - | -$13.95 M(-4.9%) | -$42.21 M(+31.7%) |
| Mar 2002 | -$32.06 M(+113.4%) | -$14.66 M(+124.3%) | -$32.06 M(+84.3%) |
| Dec 2001 | - | -$6.54 M(-7.2%) | -$17.39 M(+60.2%) |
| Sept 2001 | - | -$7.05 M(+85.3%) | -$10.85 M(+185.3%) |
| June 2001 | - | -$3.80 M | -$3.80 M |
| Mar 2001 | -$15.02 M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual cash flow from investing activities?
- What is the all time high annual CFI for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual CFI year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly CFI year-on-year change?
- What is Dr Reddys Laboratories Limited TTM cash flow from investing activities?
- What is the all time high TTM CFI for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM CFI year-on-year change?
What is Dr Reddys Laboratories Limited annual cash flow from investing activities?
The current annual CFI of RDY is -$486.60 M
What is the all time high annual CFI for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual cash flow from investing activities is $14.13 M
What is Dr Reddys Laboratories Limited annual CFI year-on-year change?
Over the past year, RDY annual cash flow from investing activities has changed by +$29.43 M (+5.70%)
What is Dr Reddys Laboratories Limited quarterly cash flow from investing activities?
The current quarterly CFI of RDY is -$226.63 M
What is the all time high quarterly CFI for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly cash flow from investing activities is $130.70 M
What is Dr Reddys Laboratories Limited quarterly CFI year-on-year change?
Over the past year, RDY quarterly cash flow from investing activities has changed by -$172.65 M (-319.80%)
What is Dr Reddys Laboratories Limited TTM cash flow from investing activities?
The current TTM CFI of RDY is -$801.71 M
What is the all time high TTM CFI for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM cash flow from investing activities is $60.80 M
What is Dr Reddys Laboratories Limited TTM CFI year-on-year change?
Over the past year, RDY TTM cash flow from investing activities has changed by -$121.29 M (-17.83%)